63 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet https://www.cnbc.com/2024/03/16/wegovy-heart-health-insurance-coverage.html Mar 16, 2024 - Some health plans and employers are still reluctant to cover Wegovy due to its hefty price tag, which they say could significantly strain their budgets.
CVS Health (CVS) Stock Moves -0.17%: What You Should Know https://www.zacks.com/stock/news/2240279/cvs-health-cvs-stock-moves-0-17-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2240279 Mar 13, 2024 - CVS Health (CVS) closed the most recent trading day at $75.08, moving -0.17% from the previous trading session.
CVS Health: Better Times Likely Ahead https://seekingalpha.com/article/4677494-cvs-health-better-times-likely-ahead?source=feed_all_articles Mar 11, 2024 - CVS Health is dealing with higher medical care costs, implementation struggles, and leadership changes. Learn why CVS stock is a Buy.
Wall Street Analysts See CVS Health (CVS) as a Buy: Should You Invest? https://www.zacks.com/stock/news/2238562/wall-street-analysts-see-cvs-health-cvs-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2238562 Mar 11, 2024 - According to the average brokerage recommendation (ABR), one should invest in CVS Health (CVS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know https://www.zacks.com/stock/news/2238497/cvs-health-corporation-cvs-is-attracting-investor-attention-here-is-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|most_searched_stocks-2238497 Mar 11, 2024 - CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
CVS Health (CVS) Down 1% Since Last Earnings Report: Can It Rebound? https://www.zacks.com/stock/news/2238122/cvs-health-cvs-down-1-since-last-earnings-report-can-it-rebound?cid=CS-ZC-FT-realtime_blog-2238122 Mar 08, 2024 - CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
CVS Health (CVS) Stock Declines While Market Improves: Some Information for Investors https://www.zacks.com/stock/news/2237629/cvs-health-cvs-stock-declines-while-market-improves-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2237629 Mar 07, 2024 - CVS Health (CVS) reachead $74.30 at the closing of the latest trading day, reflecting a -0.05% change compared to its last close.
CVS Health (CVS) Expands In-Home Diagnostic Care With New Test https://www.zacks.com/stock/news/2236218/cvs-health-cvs-expands-in-home-diagnostic-care-with-new-test?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2236218 Mar 05, 2024 - CVS Health's (CVS) new launch will enable early detection of heart arrhythmia and can help mitigate symptoms and more severe complications.
CVS and Walgreens plan to start dispensing abortion pill mifepristone in states including Mass. soon https://www.boston.com/news/health/2024/03/01/cvs-walgreens-abortion-pill-mifepristone-massachusetts-rhode-island/ Mar 01, 2024 -

Walgreens will begin dispensing the medication within a week, a spokesman said. The chain will start with some locations in New York, Pennsylvania, Massachusetts, California and Illinois.

The post CVS and Walgreens plan to start dispensing abortion pill mifepristone in states including Mass. soon appeared first on Boston.com.

CVS and Walgreens to start selling abortion pill mifepristone this month https://www.cnbc.com/2024/03/01/cvs-walgreens-to-start-selling-abortion-pill-mifepristone-this-month-.html Mar 01, 2024 - CVS and Walgreens have received certification from the FDA to dispense the commonly used mifepristone at their retail pharmacies, spokespeople told CNBC.

Pages: 1234567

Page 1>